Diff Profiles › MTBLS4046_0001_00000014

AMAD_Log_vs_AMAE_Sta

AMAD_Log vs AMAE_Sta

p-value ≤ 0.05 7 significant 2025-09-26 00:00:00 Study: MTBLS4046
10 Total Features
7 Significant
0.05 p-value Threshold

Profile details

Identifier
MTBLS4046_0001_00000014
Linked study
MTBLS4046 — Transcriptional Shift and Metabolic Adaptations during Leishmania Quiescence Using Stationary Phase and Drug Pressure as Models
Comparison
AMAD_Log vs AMAE_Sta
Group A
Amastigote stage under Log treatment. Provides insight into the effects of Log treatment on amastigote stage.
Group B
Amastigote stage under Sta treatment. Provides insight into the effects of Sta treatment on amastigote stage.
Total features tested
10
Significant features
7
p-value threshold
0.05
Ratio threshold (upper)
1.5
Ratio threshold (lower)
1/1.5
Date created
2025-09-26 00:00:00

Top hits

Metabolite ID (InChI Key) Name Direction Ratio p-value
HMFHBZSHGGEWLO-SOOFDHNKSA-N D-Ribose up 51.28 0.000122
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-Glucose up 17.73 0.000236
XOAAWQZATWQOTB-UHFFFAOYSA-N 2-ammonioethanesulfonate up 12.28 0.000985
CKLJMWTZIZZHCS-REOHCLBHSA-N L-Aspartic acid up 4.73 3.49e-05
POJWUDADGALRAB-UHFFFAOYSA-N (2,5-Dioxo-4-imidazolidinyl)urea up 3.17 0.000656
DRTQHJPVMGBUCF-XVFCMESISA-N u down 0.4919 0.00192
KTVPXOYAKDPRHY-AIHAYLRMSA-N 5-<em>O</em>-phosphono-α-<small>D</small>-ribofuranose up 1.756 0.044